Hereditary Cancer Risk Panel (47 genes)
Next-generation sequencing across 47 genes associated with hereditary cancer predisposition syndromes, including full BRCA1/BRCA2 sequencing and deletion/duplication analysis. Genetic counselling is strongly recommended both before and after this test.
- Sample type
- Whole blood
- Turnaround
- 18–25 business days
- Fasting
- Not required
- Collection
- Home visit or centre
What's measured (4 groups)
- BRCA1, BRCA2 (full sequence + del/dup)
- Lynch syndrome genes (MLH1, MSH2, MSH6, PMS2, EPCAM)
- TP53, PTEN, STK11, CDH1, PALB2, ATM, CHEK2
- 35 additional cancer-predisposition genes
How to prepare
- No fasting required
- A referring clinician's order is required
- Pre-test genetic counselling is strongly recommended
Partner accredited genomics laboratory
Results are released to your Meridian Health account and can be shared with your treating clinician. Lab results are best interpreted alongside your clinical history — book a consultation if you'd like to review them with a doctor.
Book This Test
$1,850.00Sign in to book this lab test and choose a collection slot.
Related Tests
Whole Exome Sequencing (Clinical)
Sequences all ~20,000 protein-coding genes to investigate suspected rare or undiagnosed genetic conditions.
- Whole blood
- Results in 21–28 days
- 4 result groups
Test fee
$2,450.00
Pharmacogenomic (PGx) Response Panel
Genotypes key drug-metabolising enzymes to inform how you may respond to common medication classes.
- Buccal swab
- Results in 10–14 days
- 4 result groups
Test fee
$890.00
Karyotype + Chromosomal Microarray
Detects chromosomal rearrangements plus sub-microscopic copy-number changes not visible on karyotype alone.
- Whole blood
- Results in 14–21 days
- 4 result groups
Test fee
$1,150.00